Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2025-12-25 @ 10:46 PM
NCT ID: NCT02734667
Description: Adverse events were assessed in youths only.
Frequency Threshold: 0
Time Frame: 24 months
Study: NCT02734667
Study Brief: Initiation of Continuous Glucose Monitoring at Diagnosis of Type 1 Diabetes
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
CGM at Diagnosis of T1D Participants start non-adjunctive use of CGM at diagnosis of T1D and continue for 6 months. CGM at diagnosis of T1D: Initiation of non-adjunctive CGM use at diagnosis of T1D 0 None 0 42 0 42 View
Usual Care Participants receive usual care for T1D for 6 months post diagnosis. 0 None 0 18 0 18 View
Serious Events(If Any):
Other Events(If Any):